Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Desantis

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Cells|November 27, 2021
Role of Extracellular Vesicle-Based Cell-to-Cell Communication in Multiple Myeloma ProgressionIlaria Saltarella, Aurelia Lamanuzzi, Benedetta Apollonio, et al.
Journal of Clinical Medicine|April 12, 2025
Ocular Side Effects of Dupilumab: A Comprehensive Overview of the LiteratureGiacomo Boscia, Federico Spataro, Vanessa Desantis, et al.
Journal of Clinical Medicine|December 9, 2023
The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic DevelopmentsAntonella Argentiero, Antonella Delvecchio, Rossella Fasano, et al.
Annals of Hematology|April 27, 2026
Real-world incidence of severe infections in multiple myeloma patients receiving bispecific antibodies: a meta-analysisFederico Spataro, Vanessa Desantis, Hermann Einsele, et al.
Experimental Hematology & Oncology|June 20, 2026
Real-world evidence on infection risk in multiple myeloma treated with BiTEs and CAR-T cells: a meta-analysisFederico Spataro, Vanessa Desantis, Giuseppe Dicuonzo, et al.
Journal of Infection in Developing Countries|March 6, 2026
Successful rapid intravenous desensitization to rifampicin in a patient with tuberculosisFederico Spataro, Roberto Ria, Mattia Cristallo, et al.
Cancers|April 23, 2022
The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic OpportunitiesIlaria Saltarella, Benedetta Apollonio, Aurelia Lamanuzzi, et al.
Cardiac Failure Review|September 3, 2025
Addressing Endothelial Dysfunction in Heart Failure: The Role of Endothelial Progenitor Cells and New Treatment HorizonsEugenio Carulli, Marialuisa Sveva Marozzi, Maria Cristina Carella, et al.
Journal of Clinical Medicine|May 14, 2022
The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical ValueVanessa Desantis, Francesco Domenico Savino, Antonietta Scaringella, et al.
Journal of Clinical Medicine|November 11, 2022
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug ResistanceAssunta Melaccio, Antonia Reale, Ilaria Saltarella, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Cells|November 27, 2021
Role of Extracellular Vesicle-Based Cell-to-Cell Communication in Multiple Myeloma ProgressionIlaria Saltarella, Aurelia Lamanuzzi, Benedetta Apollonio, et al.
Journal of Clinical Medicine|April 12, 2025
Ocular Side Effects of Dupilumab: A Comprehensive Overview of the LiteratureGiacomo Boscia, Federico Spataro, Vanessa Desantis, et al.
Journal of Clinical Medicine|December 9, 2023
The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic DevelopmentsAntonella Argentiero, Antonella Delvecchio, Rossella Fasano, et al.
Annals of Hematology|April 27, 2026
Real-world incidence of severe infections in multiple myeloma patients receiving bispecific antibodies: a meta-analysisFederico Spataro, Vanessa Desantis, Hermann Einsele, et al.
Experimental Hematology & Oncology|June 20, 2026
Real-world evidence on infection risk in multiple myeloma treated with BiTEs and CAR-T cells: a meta-analysisFederico Spataro, Vanessa Desantis, Giuseppe Dicuonzo, et al.
Journal of Infection in Developing Countries|March 6, 2026
Successful rapid intravenous desensitization to rifampicin in a patient with tuberculosisFederico Spataro, Roberto Ria, Mattia Cristallo, et al.
Cancers|April 23, 2022
The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic OpportunitiesIlaria Saltarella, Benedetta Apollonio, Aurelia Lamanuzzi, et al.
Cardiac Failure Review|September 3, 2025
Addressing Endothelial Dysfunction in Heart Failure: The Role of Endothelial Progenitor Cells and New Treatment HorizonsEugenio Carulli, Marialuisa Sveva Marozzi, Maria Cristina Carella, et al.
Journal of Clinical Medicine|May 14, 2022
The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical ValueVanessa Desantis, Francesco Domenico Savino, Antonietta Scaringella, et al.
Journal of Clinical Medicine|November 11, 2022
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug ResistanceAssunta Melaccio, Antonia Reale, Ilaria Saltarella, et al.
Pageof 6